Boston Scientific expects first quarter 2026 reported revenue growth to be in a range of 10.5% to 12% versus first quarter 2025. Excluding foreign exchange, operational and organic revenue growth for ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results